Viraleze was developed for application in the nasal cavity to help reduce exposure to respiratory viruses, including SARS-CoV-2. The product is registered for sale in Europe and India, and available online in certain markets
In some countries such as France, Italy, Spain and the Balkan region, Menarini Group will lead the commercialisation effort, as part of an exclusive licensing agreement signed with Glenmark
The company witnesses strong growth across its India, Africa, and emerging markets businesses, while securing regulatory approval for the first AB-rated gVentolin in the U.S. market
This marks a meaningful step in the company's continued expansion in the region
Inspection included drug device combinations covering our recent filing in nasal sprays domain
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
Subscribe To Our Newsletter & Stay Updated
